rs121965081
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM5
The NM_000260.4(MYO7A):c.731G>A(p.Arg244His) variant causes a missense change. The variant allele was found at a frequency of 0.000431 in 1,612,286 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R244P) has been classified as Pathogenic.
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.731G>A | p.Arg244His | missense_variant | 7/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.731G>A | p.Arg244His | missense_variant | 7/49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.731G>A | p.Arg244His | missense_variant | 7/49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.698G>A | p.Arg233His | missense_variant | 8/50 | 1 | ENSP00000386635.2 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000270 AC: 67AN: 247714Hom.: 0 AF XY: 0.000208 AC XY: 28AN XY: 134534
GnomAD4 exome AF: 0.000447 AC: 653AN: 1460094Hom.: 1 Cov.: 32 AF XY: 0.000439 AC XY: 319AN XY: 726276
GnomAD4 genome AF: 0.000276 AC: 42AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74360
ClinVar
Submissions by phenotype
not provided Uncertain:5Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 28, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 08, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | MYO7A: PP3 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 12, 2016 | The p.Arg244His variant in MYO7A has been previously reported in one individual with hearing loss by our laboratory who had an alternate explanation for their h earing loss in another gene. In addition, it has been identified in 34/65670 of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs121965081); however this frequency is not high enough to rule out a pathogenic role. A different amino acid change at the same position, p.Arg244Pro, has been reported in the homozygous state in 1 Chinese individual with hearing loss and vestibular dysfunction and segregated with disease in 2 af fected siblings (Liu 1997). Computational prediction tools and conservation anal ysis suggest the variant may impact the protein. These data suggest that variant s at this amino acid position are not tolerated; however this information is ins ufficient to assume pathogenicity. In summary, the clinical significance of the p.Arg244His is uncertain. - |
Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 21, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at